Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Launch of the Gustave Roussy Prize to honor scientific innovation in oncology
On
Villejuif, November 20, 2024
Launch of the Gustave Roussy Prize to honor scientific innovation in oncology
To mark the 150th anniversary of its founder’s birth and the upcoming centennial of the Institute that bears his name, Gustave Roussy is proud to announce the launch of the Gustave Roussy Prize. This exceptional annual award aims to recognize a researcher whose scientific discoveries have significantly impacted cancer patient care.
A visionary physician and renowned scientist, Professor Gustave Roussy revolutionized cancer care by establishing the first consultation dedicated to cancer patients in 1921. The newly launched Gustave Roussy Prize embodies the commitment of the Institute he founded, now focused on personalized approaches to better prevent, challenge prognoses, reduce side effects, and enhance the quality and length of life for every patient.
Supported by Pierre Fabre Laboratories as founding sponsor, the Gustave Roussy Prize is endowed with €200,000 annually. It will honor a leading figure in oncology research whose discoveries have significantly improved cancer patient care. This award ranks among the most generous distinctions worldwide in the field of cancer research.
“We are very proud to support this new prize. We are committed to encouraging Gustave Roussy’s initiatives as Europe’s leading cancer center, recognized for its multidisciplinary expertise and aligned with our purpose: every time we care for a single person, we make the world better. This award also extends the numerous development collaborations we have shared with Gustave Roussy over the past 25 years,” says Éric Ducournau, CEO of Pierre Fabre Laboratories.
“The Gustave Roussy Prize embodies our unwavering commitment to scientific innovation, which is essential to pushing the boundaries of oncology and offering patients increasingly effective and personalized treatments. By honoring researchers whose discoveries transform the lives of patients, we celebrate the forward-thinking vision of our founder and reaffirm our determination to cure cancer in the 21st century,” ads Professor Fabrice Barlesi, CEO of Gustave Roussy.
An Award Aligned with Contemporary Medical Challenges
The Gustave Roussy Prize is designed to honor individuals behind scientific breakthroughs with tangible benefits for cancer patients. It is open to internationally renowned researchers whose work significantly advances the treatment, understanding, or prevention of cancers.
For this inaugural edition of the Gustave Roussy Prize, applications must be submitted by December 20, 2024, at the following link: https://forms.office.com/e/rBSaqphxwG.
Award Ceremony on February 4, 2025
The winner will be selected by a jury of international experts, independent of Gustave Roussy, who will evaluate the applications based on the impact of the researcher’s work on patients. For this first edition, the Gustave Roussy Prize ceremony will be held on February 4, 2025, coinciding with World Cancer Day.
This prestigious award reflects the Institute’s dedication and the enduring vision of Professor Gustave Roussy by placing research at the service of patients and encouraging researchers to continue their vital efforts in the fight against cancer.
pr-gustave-roussy-prize-201124.pdf
Press contact
If you are a journalist and have a question, please contact:
Claire Parisel or Léona Pinto
Tel. +33 1 42 11 50 59
Tel. +33 1 42 11 63 59
Mob. +33 6 17 66 00 26
Email
The Media Team cannot respond to patient inquiries.
Last press releases
-
Gold september: two new research programmes launched to tackle childhood cancers
Two of Gustave Roussy’s four new medical and scientific programmes are dedicated to childhood cancers. The first, DECRIPT, aims to improve understanding of the role played by genetics in the development of certain childhood cancers, as well as second cancers that may occur in adulthood. The second, INSPIRE, will draw on the knowledge and techniques already developed at the Institute to create organoids, with the aim of deciphering the mechanisms underlying metastasis and resistance to treatment.
-
Prof. Fabrice Barlesi reappointed at the head of Gustave Roussy, the leading cancer center in France and Europe
By order of Ms. Stéphanie Rist, Minister of Health, Families, Autonomy and Persons with Disabilities, dated 27 July 2026, Professor Fabrice Barlesi has been reappointed as Director General of Gustave Roussy, effective 1 August 2026. At the helm of the Institute for five more years, Prof. Barlesi will continue the transformations undertaken during his first term. This renewal reflects the confidence placed in the project led by the institution to accelerate progress in the fight against cancer, foster and support the development of innovations set to change the future of oncology, and strengthen the influence of one of the world's leading cancer centers.
-
Route du Rhum 2026 Jean Le Cam and Christophe Rateau to sail for Gustave Roussy
For the Route du Rhum - Destination Guadeloupe 2026, Jean Le Cam and Christophe Rateau will sail under the colors of Gustave Roussy, the leading cancer center in France and Europe. Competing respectively in the Vintage and Class40 categories, the two skippers will carry the Institute's mission to the general public, supporting cancer research and raising awareness of prevention, innovation and patient care.
-
Owkin and Gustave Roussy partner to bring K Pro into real-world clinical practice
Owkin and Gustave Roussy, Europe's leading cancer center, today announced a partnership to test K Pro directly within the hospital's real-world clinical and research workflows.
